DPP-4 inhibitors may improve the mortality of coronavirus disease 2019: A meta-analysis

• Yan Yang ,

  Contributed equally to this work with: Yan Yang, Zixin Cai

  Roles Conceptualization, Data curation, Formal analysis, Methodology, Software, Writing – original draft

  Affiliation National Clinical Research Center for Metabolic Diseases, Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China

  ⨯
• Zixin Cai ,

  Contributed equally to this work with: Yan Yang, Zixin Cai

  Roles Data curation, Formal analysis, Investigation, Methodology, Resources, Software, Validation, Visualization

  Affiliation National Clinical Research Center for Metabolic Diseases, Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China

  ⨯
• Jingjing Zhang

  Roles Funding acquisition, Project administration, Resources, Supervision, Validation, Visualization, Writing – review & editing

  * E-mail: Doctorzhangjj@csu.edu.cn

  Affiliation National Clinical Research Center for Metabolic Diseases, Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry of Education, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China

  https://orcid.org/0000-0002-9155-8979

  ⨯